-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_disposition-comments.pdf
January 15, 2016 - say this, based on knowledge
of basic science and VEGF, steroids only helpful during
proliferative phase … TEP reviewer #5 Introduction 1/25- Recent literature no longer recognizes a plateau
phase. … growth”, would state
that they may have more prolonged growth (or could say
that the proliferative phase … would reword the sentence
that states that “ulceration typically occurs later in the
proliferation phase … . . . “
Ulceration may occur throughout the proliferative phase and
often occurs early.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse_research-protocol.pdf
April 28, 2010 - Limits Humans
Clinical Trial; Meta-Analysis; Randomized Controlled Trial; Review; Clinical Trial,
Phase … I; Clinical Trial, Phase II; Clinical Trial, Phase III; Clinical Trial, Phase IV;
Comparative Study … We will retrieve and review the full text of all titles included during the title/abstract review
phase
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/what-is-the-comparative-effectiveness-of-different-models-of-survivorship-care-and-sets-of-services-on-late-and-long-term-net-health-outcomes-eg-for-breast-cancer
June 01, 2011 - The focus on survivorship as a distinct phase of the cancer continuum is important to ensure that these
-
effectivehealthcare.ahrq.gov/sites/default/files/s3.pdf
October 01, 2007 - against Duke.3 However, my
first and most impressive interactions with Harry were during the early phase
-
effectivehealthcare.ahrq.gov/sites/default/files/it-architecture-for-post-marketing-surveillance-arizona-cert.pdf
September 01, 2007 - early on during clinical trials, serious adverse drug effects can still go
undetected during this phase … The FDA monitors for adverse drug events in the
post-marketing phase through the MedWatch program ( … focus is on the
detection of adverse drug events in an outpatient setting and in the post marketing phase … Information flows in the post approval phase
While the FDA and drug companies are able to use broadcast
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicine-safety-call-center_research.pdf
September 01, 2007 - early on during clinical trials, serious adverse drug effects can still go
undetected during this phase … The FDA monitors for adverse drug events in the
post-marketing phase through the MedWatch program ( … focus is on the
detection of adverse drug events in an outpatient setting and in the post marketing phase … Information flows in the post approval phase
While the FDA and drug companies are able to use broadcast
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-260-improved-cancer-outcomes-executive-summary.pdf
May 01, 2023 - Geriatric
analysis from PRODIGE 20 randomized
phase II trial evaluating bevacizumab +
chemotherapy … combined
with postoperative early oral intake in
elderly patients undergoing hepatectomy
with acute-phase … Oral
nutritional supplements versus a regular diet
alone for body weight loss after
gastrectomy: a phase
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-260-improved-cancer-outcomes-executive-summary_0.pdf
May 01, 2023 - Geriatric
analysis from PRODIGE 20 randomized
phase II trial evaluating bevacizumab +
chemotherapy … combined
with postoperative early oral intake in
elderly patients undergoing hepatectomy
with acute-phase … Oral
nutritional supplements versus a regular diet
alone for body weight loss after
gastrectomy: a phase
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pharma-nonpharma-ptsd-2022-update-executive-summ.pdf
January 01, 2022 - since we will not complete updated RoB assessment for all 389
studies from the previous report in this phase
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/multiple-sclerosis_executive.pdf
April 01, 2015 - For
example, a patient newly diagnosed with MS in the novice
phase of learning about MS would likely … After excluding articles at the title
and abstract phase, full texts of 198 articles were reviewed … Furthermore, some patients with
RRMS never transition to a clear secondary progressive
phase. … a first clinical event
suggestive of multiple sclerosis: 5-year active treatment extension
of the phase … Long-term follow-
up of a phase 2 study of oral teriflunomide in relapsing multiple
sclerosis: safety
-
effectivehealthcare.ahrq.gov/products/cervical-ripening/protocol
January 16, 2020 - cm dilation for fetal distress
Cervical assessment at time of admission (e.g., latent vs. active phase … cm dilation for fetal distress
Cervical assessment at time of admission (e.g., latent vs. active phase … cm dilation for fetal distress
Cervical assessment at time of admission (e.g., latent vs. active phase … cm dilation for fetal distress
Cervical assessment at time of admission (e.g., latent vs. active phase
-
effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1506.pdf
June 01, 2015 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in
phase … Results
The table below lists five topics for which (1) preliminary phase III data for drugs were … A phase IV trial is ongoing for patients with
tuberculosis. … Failure to determine these thresholds during Phase 2 is
believed to be one of the main reasons for … Phase 3 failures.”9
One phase IV clinical trial (NCT01960257) is ongoing to evaluate the cost and perception
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/prevent-hai-protocol.pdf
April 16, 2024 - ,ab)
#15 RCTs ('random sample'/de OR 'randomization'/de OR 'randomized
controlled trial'/exp OR 'phase … 3':ti,ab OR 'phase iii':ti,ab
OR random*:ti,ab OR RCT:ti,ab)
#16 Observational/
Cohort Studies/
-
effectivehealthcare.ahrq.gov/sites/default/files/12_pregnancy_potential_high_impact_2012-12-11.pdf
January 01, 2012 - inclusion are those interventions expected to be within 0–4 years of potential diffusion (e.g., in
phase … Results
The table below lists the three topics for which (1) preliminary phase III data were available … for
drugs, phase II or III data were available for devices and procedures, or some human data were
-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1312.pdf
December 01, 2013 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in
phase … Results
The table below lists two topics for which preliminary phase III data were available for a drug … The 6-month buprenorphine implant completed phase III trials, one of
which was funded by the National
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1312.pdf
December 01, 2013 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in
phase … Results
The table below lists the three topics for which (1) preliminary phase III data for drugs were … The Horizon Scanning System is tracking several
drugs in late-phase development.
-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1412.pdf
December 01, 2014 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in
phase … Results
The table below lists the three topics for which (1) preliminary phase III or bioequivalence … Two late-phase multicenter trials are ongoing, and we continue to track this
topic.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children-update_research-protocol.pdf
December 04, 2015 - induced psychotic disorder, or prodromal phase (ultra high-risk). … phase!or!features!of!disorder,!and!
antipsychotic!treatment!history?!
2.! What!are!the!benefits,! … phase!or!features!of!disorder,!and!
antipsychotic!treatment!history?!
(b)!!Do!the!benefits!vary! … phase!and!features!of!disorder!(e.g.,!acute!mania!vs.!maintenance!treatment![bipolar!
disorder],! … from an RCT phase to a controlled, observational phase, we will consider these two different
studies
-
effectivehealthcare.ahrq.gov/sites/default/files/manges.pdf
January 06, 2017 - ENVIRONMENTAL PROTECTION AGENCY
INNOVATIONS CONFERENCE -- ENVIRONMENTAL PROTECTION AGENCY
SPEAKER: ELLEN MANGES,
SENIOR ADVISOR, OFFICE OF SOLID WASTE AND EMERGENCY RESPONSE (OSWER)
ENVIRONMENTAL PROTECTION AGENCY (EPA)
MANGES: My name is Ellen Manges. I'm a senior advisor. I…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/sleep-apnea_surveillance.pdf
April 01, 2012 - AHRQ Comparative Effectiveness Review
Surveillance Program
CER #32:
Diagnosis and Treatment of Obstructive Sleep Apnea
in Adults
Original release date:
August 8, 2011
Surveillance Report:
July, 2012
Key Findings:
- The conclusions for KQ2 (phased testing), KQ3
(preoperative screening), KQ6 (compliance…